J A Peterson1, S A Maroney1, W Zwifelhofer1, J P Wood1, K Yan2, R S Bercovitz2, R K Woods3,4, A E Mast1,5. 1. Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, USA. 2. Departments of Pathology and Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. 3. HermaHeart Center, Division of Pediatric Cardiothoracic Surgery, Children's Hospital of Wisconsin, Milwaukee, WI, USA. 4. Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA. 5. Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
Abstract
Essentials Heparin-protamine balance (HPB) modulates bleeding after neonatal cardiopulmonary bypass (CPB). HPB was examined in 44 neonates undergoing CPB. Post-operative bleeding occurred in 36% and heparin rebound in 73%. Thrombin-initiated fibrin clot kinetic assay and partial thromboplastin time best assessed HPB. SUMMARY: Background Neonates undergoing cardiopulmonary bypass (CPB) are at risk of excessive bleeding. Blood is anticoagulated with heparin during CPB. Heparin activity is reversed with protamine at the end of CPB. Paradoxically, protamine also inhibits blood coagulation when it is dosed in excess of heparin. Objectives To evaluate heparin-protamine balance in neonates undergoing CPB by using research and clinical assays, and to determine its association with postoperative bleeding. Patients/Methods Neonates undergoing CPB in the first 30 days of life were studied. Blood samples were obtained during and after surgery. Heparin-protamine balance was assessed with calibrated automated thrombography, thrombin-initiated fibrin clot kinetic assay (TFCK), activated partial thromboplastin time (APTT), anti-FXa activity, and thromboelastometry. Excessive postoperative bleeding was determined by measurement of chest tube output or the development of cardiac tamponade. Results and Conclusions Of 44 neonates enrolled, 16 (36%) had excessive postoperative bleeding. The TFCK value was increased. By heparin in neonatal blood samples, but was only minimally altered by excess protamine. Therefore, it reliably measured heparin in samples containing a wide range of heparin and protamine concentrations. The APTT most closely correlated with TFCK results, whereas anti-FXa and thromboelastometry assays were less correlative. The TFCK and APTT assay also consistently detected postoperative heparin rebound, providing an important continued role for these long-established coagulation tests in the management of postoperative bleeding in neonates requiring cardiac surgical repair. None of the coagulation tests predicted the neonates who experienced postoperative bleeding, reflecting the multifactorial causes of bleeding in this population.
Essentials Heparin-protamine balance (HPB) modulates bleeding after neonatal cardiopulmonary bypass (CPB). HPB was examined in 44 neonates undergoing CPB. Post-operative bleeding occurred in 36% and heparin rebound in 73%. Thrombin-initiated fibrin clot kinetic assay and partial thromboplastin time best assessed HPB. SUMMARY: Background Neonates undergoing cardiopulmonary bypass (CPB) are at risk of excessive bleeding. Blood is anticoagulated with heparin during CPB. Heparin activity is reversed with protamine at the end of CPB. Paradoxically, protamine also inhibits blood coagulation when it is dosed in excess of heparin. Objectives To evaluate heparin-protamine balance in neonates undergoing CPB by using research and clinical assays, and to determine its association with postoperative bleeding. Patients/Methods Neonates undergoing CPB in the first 30 days of life were studied. Blood samples were obtained during and after surgery. Heparin-protamine balance was assessed with calibrated automated thrombography, thrombin-initiated fibrin clot kinetic assay (TFCK), activated partial thromboplastin time (APTT), anti-FXa activity, and thromboelastometry. Excessive postoperative bleeding was determined by measurement of chest tube output or the development of cardiac tamponade. Results and Conclusions Of 44 neonates enrolled, 16 (36%) had excessive postoperative bleeding. The TFCK value was increased. By heparin in neonatal blood samples, but was only minimally altered by excess protamine. Therefore, it reliably measured heparin in samples containing a wide range of heparin and protamine concentrations. The APTT most closely correlated with TFCK results, whereas anti-FXa and thromboelastometry assays were less correlative. The TFCK and APTT assay also consistently detected postoperative heparin rebound, providing an important continued role for these long-established coagulation tests in the management of postoperative bleeding in neonates requiring cardiac surgical repair. None of the coagulation tests predicted the neonates who experienced postoperative bleeding, reflecting the multifactorial causes of bleeding in this population.
Authors: Nina A Guzzetta; Nadine N Allen; Elizabeth C Wilson; Gregory S Foster; Alexandra C Ehrlich; Bruce E Miller Journal: Anesth Analg Date: 2015-02 Impact factor: 5.108
Authors: Linda Shore-Lesserson; Robert A Baker; Victor A Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John W Hammon Journal: Ann Thorac Surg Date: 2018-01-19 Impact factor: 4.330
Authors: Nina A Guzzetta; Heather G Monitz; Janet D Fernandez; Tom M Fazlollah; Andrea Knezevic; Bruce E Miller Journal: Anesth Analg Date: 2010-06-02 Impact factor: 5.108
Authors: Rachel S Bercovitz; Allison C Shewmake; Debra K Newman; Robert A Niebler; John P Scott; Eckehard Stuth; Pippa M Simpson; Ke Yan; Ronald K Woods Journal: J Thorac Cardiovasc Surg Date: 2017-12-13 Impact factor: 5.209
Authors: Veronika Binder; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Carsten Scavenius; Endy Spriet; Anne Karin Nyhaug; Helen M Roberts; Iain L C Chapple; Annelie Hellvard; Nicolas Delaleu; Piotr Mydel Journal: Thromb Haemost Date: 2017-04-06 Impact factor: 5.249
Authors: Nicole M J Zwifelhofer; Rachel S Bercovitz; Regina Cole; Ke Yan; Pippa M Simpson; Alyssa Moroi; Peter J Newman; Robert A Niebler; John P Scott; Eckehard A D Stuth; Ronald K Woods; D Woodrow Benson; Debra K Newman Journal: Thromb Haemost Date: 2019-11-21 Impact factor: 5.249
Authors: Julie A Peterson; Susan A Maroney; Nicholas D Martinez; Alan E Mast Journal: Arterioscler Thromb Vasc Biol Date: 2021-04-08 Impact factor: 10.514